Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
2026 World Cup
Rewards
Square
Latest
Hot
News
Profile

The innovative drug sector performed actively in early trading, with Yuandong Biotech rising over 10%.

K-LinePoet
The innovative drug sector showed strong performance in early trading. Yuandong Biologics and Tri-Prime Gene rose by more than 10%, while Ganlee Pharmaceutical, Hotgen Biotech, Asieris Pharmaceuticals, and Yifang Biotech followed higher. As for related ETFs, the STAR Market Innovation Drug ETF by Huatai (589120) rose 1.11%, with trading volume of 93.815 million yuan, while the Innovation Drug ETF by Fullgoal (159748) rose 1.93%, with trading volume of 95.6766 million yuan. On the news front, the General Office of the National Medical Products Administration publicly solicited comments on the “Announcement on Matters Related to Optimizing Review and Approval of Cell and Gene Therapy Drugs (Draft for Comments).” It said that support will be provided for innovative R&D of cell and gene therapy drugs guided by clinical value, and that eligible cell and gene therapy drugs will be included in the 30-day fast-track channel for the review and approval of innovative drug clinical trials.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments

  • Pinned

Sitemap